Pharma News Intelligence June 21, 2024
A report from the Congressional Budget Office estimates that doubling hepatitis C treatment among Medicaid enrollees could save $7 billion.
A nonpartisan analysis for the United States Congress published by the Congressional Budget Office found that increasing access to hepatitis C treatment among Medicaid enrollees could have significant financial benefits over the next decade. More specifically, the report estimates that doubling access could save $7 billion in healthcare costs in the next ten years.
Hepatitis C is a viral infection spread through direct contact with infected blood. The infection typically begins with an acute phase that is often asymptomatic; however, over time, long-term infections called chronic hepatitis C can damage the liver.
The report explains that the condition’s prevalence is...
Today's Sponsors
Today's Sponsor